Literature DB >> 13011204

Distribution and fate of intravenously administered modified human globin and its effect on blood volume; studies utilizing I131 tagged globin.

S A BERSON, R S YALOW, J POST, L H WISHAM, K N NEWERLY, M J VILLAZON, O N VAZQUEZ.   

Abstract

Entities:  

Keywords:  BLOOD; BLOOD PROTEINS

Mesh：

Substances：

Year:  1953        PMID： 13011204      PMCID： PMC436523          DOI： 10.1172/JCI102706

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  15 in total

1.  Metabolic studies with I131 labeled thyroid compounds: distribution and excretion of radiodiiodotyrosine in human beings.

Authors:  A ALBERT; F R KEATING
Journal:  J Clin Endocrinol Metab       Date:  1951-09       Impact factor: 5.958

2.  The determination of thyroidal and renal plasma I131 clearance rates as a routine diagnostic test of thyroid dysfunction.

Authors:  S A BERSON; R S YALOW; J SORRENTINO; B ROSWIT
Journal:  J Clin Invest       Date:  1952-02       Impact factor: 14.808

3.  Determination of trapped plasma in the centrifuged erythrocyte volume of normal human blood with radioiodinated (I131) human serum albumin and radiosodium (Na24).

Authors:  O N VAZQUEZ; K NEWERLY; R S YALOW; S A BERSON
Journal:  J Lab Clin Med       Date:  1952-04

4.  Effects of modified human globin in normal human subjects.

Authors:  J L BRANDT; A CACCESE; V GINSBERG
Journal:  Proc Soc Exp Biol Med       Date:  1951-05

5.  The use of K42 tagged erythrocytes in blood volume determinations.

Authors:  R S YALOW; S A BERSON
Journal:  Science       Date:  1951-07-06       Impact factor: 47.728

6.  The effects of an increase in plasma volume on the metabolism and excretion of water and electrolytes by normal subjects.

Authors:  L G WELT; J ORLOFF
Journal:  J Clin Invest       Date:  1951-07       Impact factor: 14.808

7.  Modified globin. I. Method for preparation from human erythrocytes.

Authors:  M M STRUMIA; A B SAMPLE
Journal:  J Lab Clin Med       Date:  1951-06

8.  The biological decay curve of P32 tagged erythrocytes; application to the study of acute changes in blood volume.

Authors:  S A BERSON; R S YALOW; A AZULAY; S SCHREIBER; R BERNARD; B ROSWIT
Journal:  J Clin Invest       Date:  1952-06       Impact factor: 14.808

9.  The use of K42 or P32 labeled erythrocytes and I131 tagged human serum albumin in simultaneous blood volume determinations.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1952-06       Impact factor: 14.808

10.  The zone of localization of antibodies. V. An attempt to saturate antibody-binding sites in mouse kidney.

Authors:  D PRESSMAN; H N EISEN
Journal:  J Immunol       Date:  1950-04       Impact factor: 5.422
View more
  7 in total

1.  The iodide trapping and binding functions of the thyroid.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

2.  Blood volume alterations in congestive heart failure.

Authors:  S S SCHREIBER; A BAUMAN; R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1954-04       Impact factor: 14.808

3.  The use of modified globin as a protein supplement in normal individuals.

Authors:  C WATERHOUSE; E H KEUTMANN; L D FENNINGER
Journal:  J Clin Invest       Date:  1953-10       Impact factor: 14.808

4.  Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies.

Authors:  S A BERSON; R S YALOW; S S SCHREIBER; J POST
Journal:  J Clin Invest       Date:  1953-08       Impact factor: 14.808

5.  Nutritive adequacy and clinical tolerance of modified human globin.

Authors:  G J GABUZDA; G B PHILLIPS; C S DAVIDSON
Journal:  J Clin Invest       Date:  1953-09       Impact factor: 14.808

6.  Blood volume in health and disease.

Authors:  S A BERSON
Journal:  Bull N Y Acad Med       Date:  1954-10

7.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.